Topotecan and the development of scleroderma or a scleroderma-like illness.
Ene-Stroescu
Daniel
D
Ellman
Michael H
MH
Peterson
Carol E
CE
D000970:Antineoplastic Agents / Q000009:adverse effects*; D005260:Female; D006801:Humans; D008875:Middle Aged; D012594:Scleroderma, Localized / Q000139:chemically induced*; D019772:Topotecan / Q000009:adverse effects*
D000970:Antineoplastic Agents; D019772:Topotecan